281 related articles for article (PubMed ID: 32120229)
1. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Khorrami M; Bera K; Leo P; Vaidya P; Patil P; Thawani R; Velu P; Rajiah P; Alilou M; Choi H; Feldman MD; Gilkeson RC; Linden P; Fu P; Pass H; Velcheti V; Madabhushi A
Lung Cancer; 2020 Apr; 142():90-97. PubMed ID: 32120229
[TBL] [Abstract][Full Text] [Related]
2. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
3. Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.
Mayne NR; Mallipeddi MK; Darling AJ; Jeffrey Yang CF; Eltaraboulsi WR; Shoffner AR; Naqvi IA; D'Amico TA; Berry MF
Clin Lung Cancer; 2020 Sep; 21(5):407-414. PubMed ID: 32376115
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.
Khorrami M; Bera K; Thawani R; Rajiah P; Gupta A; Fu P; Linden P; Pennell N; Jacono F; Gilkeson RC; Velcheti V; Madabhushi A
Eur J Cancer; 2021 May; 148():146-158. PubMed ID: 33743483
[TBL] [Abstract][Full Text] [Related]
5. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
[TBL] [Abstract][Full Text] [Related]
6. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
7. Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".
Ekeke CN; Mitchell C; Schuchert M; Dhupar R; Luketich JD; Okusanya OT
Clin Lung Cancer; 2021 Jan; 22(1):e132-e135. PubMed ID: 33144072
[TBL] [Abstract][Full Text] [Related]
8. Survival disparities following surgery among patients with different histological types of non-small cell lung cancer.
Grosu HB; Manzanera A; Shivakumar S; Sun S; Noguras Gonzalez G; Ost DE
Lung Cancer; 2020 Feb; 140():55-58. PubMed ID: 31865279
[TBL] [Abstract][Full Text] [Related]
9. The progression of non-small cell lung cancer from diagnosis to surgery.
McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
[TBL] [Abstract][Full Text] [Related]
10. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer.
Higashiyama M; Miyazaki R; Yamamoto H; Anayama T; Kikuchi S; Hirohashi K; Okami J; Maniwa T; Kimura T; Orihashi K; Imamura F
BMC Cancer; 2020 Nov; 20(1):1100. PubMed ID: 33183251
[TBL] [Abstract][Full Text] [Related]
11. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
Rajaram R; Correa AM; Xu T; Nguyen QN; Antonoff MB; Rice D; Mehran R; Roth J; Walsh G; Swisher S; Hofstetter WL; Vaporciyan A; Cascone T; Tsao AS; Papadimitrakopoulou VA; Gandhi S; Liao Z; Sepesi B
Clin Lung Cancer; 2020 Jul; 21(4):e294-e301. PubMed ID: 32089476
[TBL] [Abstract][Full Text] [Related]
12. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil P; Velu P; Rajiah P; Gilkeson R; Feldman M; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 32123864
[TBL] [Abstract][Full Text] [Related]
13. Conditional Survival of Surgically Treated Patients with Lung Cancer: A Comprehensive Analyses of Overall, Recurrence-free, and Relative Survival.
Shin DW; Cho JH; Yoo JE; Cho J; Yoon DW; Lee G; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
Cancer Res Treat; 2021 Oct; 53(4):1057-1071. PubMed ID: 33705624
[TBL] [Abstract][Full Text] [Related]
14. Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
Fink-Neuboeck N; Lindenmann J; Porubsky C; Fediuk M; Anegg U; Maier A; Smolle J; Lamont E; Smolle-Juettner FM
Clin Lung Cancer; 2020 Jul; 21(4):333-340. PubMed ID: 32273257
[TBL] [Abstract][Full Text] [Related]
15. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
[TBL] [Abstract][Full Text] [Related]
16. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
17. Integrating Imaging, Histologic, and Genetic Features to Predict Tumor Mutation Burden of Non-Small-Cell Lung Cancer.
Zhang N; Wu J; Yu J; Zhu H; Yang M; Li R
Clin Lung Cancer; 2020 May; 21(3):e151-e163. PubMed ID: 31734072
[TBL] [Abstract][Full Text] [Related]
18. A SUV
Ye L; Xu F; Shi S; Zeng Z; Jin X; Huang Y; Lu C; Gu J; Ge D; He J
Clin Transl Oncol; 2018 Aug; 20(8):1026-1034. PubMed ID: 29327241
[TBL] [Abstract][Full Text] [Related]
19. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment
Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
